Fibclot

Human Fibrinogen (Fibclot) is a plasma-derived protein used to manage bleeding disorders. This intravenous medication supports blood clotting and is essential for surgical procedures or trauma-related bleeding.

Human Fibrinogen, also known as Fibclot, is primarily used to control bleeding in patients with congenital fibrinogen deficiency. It is often administered during surgical procedures or in cases of trauma to promote blood clotting and prevent excessive blood loss. This medication is crucial for individuals who require rapid clotting support due to inherited or acquired conditions.

When administered intravenously, Human Fibrinogen works to enhance the body's natural clotting process. Patients may experience improved clotting at the site of injury or surgical incision. As with any medication, individual responses can vary, and some users might notice temporary side effects.

Human Fibrinogen should be used under medical supervision to ensure proper administration and monitoring. Patients with a history of allergic reactions to plasma-derived products should exercise caution. Always follow healthcare provider instructions for safe use.

Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.